Researchers at the Perelman School of Medicine at the University of Pennsylvania have identified a brain immune protein that may play a major role in the progression of Parkinson's disease (PD). Their findings, published in Neuron, suggest that blocking this protein with monoclonal antibodies could eventually lead to treatments that slow the disease in its earliest stages.
The protein, known as glycoprotein nonmetastatic melanoma B (GPNMB), appears to...

10 hours ago
9








English (US) ·